MEDIPOST Co., Ltd. (KOSDAQ:078160)
15,310
+270 (1.80%)
At close: Jan 19, 2026
MEDIPOST Market Cap
MEDIPOST has a market cap or net worth of 598.4 billion as of January 16, 2026. Its market cap has increased by 29.61% in one year.
Market Cap
598.40B
Enterprise Value
573.61B
Revenue
73.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,310.00
Market Cap Chart
Since July 29, 2005, MEDIPOST's market cap has increased from 189.41B to 598.40B, an increase of 215.94%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 598.40B | -15.83% |
| Dec 30, 2025 | 710.97B | 80.99% |
| Dec 30, 2024 | 392.82B | 41.18% |
| Dec 28, 2023 | 278.25B | 15.66% |
| Dec 29, 2022 | 240.56B | -30.37% |
| Dec 30, 2021 | 345.51B | -35.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.73T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.43T |